Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trond Viset

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
BJU International|January 22, 2009
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based studyRune Kvåle, Bjørn Møller, Rolf Wahlqvist, et al.
Histology and Histopathology|February 8, 2013
Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patientsReidar Alexander Vigen, Yosuke Kodama, Trond Viset, et al.
Scandinavian Journal of Gastroenterology|November 18, 2011
Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitorConstantin S Jianu, Ove J Lange, Trond Viset, et al.
Investigative Radiology|September 27, 2012
Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathologyKirsten M Selnæs, Arend Heerschap, Line R Jensen, et al.
Plos One|April 30, 2013
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressivenessGuro F Giskeødegård, Helena Bertilsson, Kirsten M Selnæs, et al.
Oncotarget|September 11, 2018
"Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signalingCaroline Krogh Søgaard, Augun Blindheim, Lisa M Røst, et al.
Oncotarget|June 9, 2016
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancerAilin Falkmo Hansen, Elise Sandsmark, Morten Beck Rye, et al.
Oncotarget|December 29, 2016
A novel non-canonical Wnt signature for prostate cancer aggressivenessElise Sandsmark, Ailin Falkmo Hansen, Kirsten M Selnæs, et al.
Communications Biology|November 7, 2024
Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancerMaria K Andersen, Sebastian Krossa, Elise Midtbust, et al.
Nature Communications|November 19, 2025
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironmentSebastian Krossa, Maria K Andersen, Elise M Sandholm, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
BJU International|January 22, 2009
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based studyRune Kvåle, Bjørn Møller, Rolf Wahlqvist, et al.
Histology and Histopathology|February 8, 2013
Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patientsReidar Alexander Vigen, Yosuke Kodama, Trond Viset, et al.
Scandinavian Journal of Gastroenterology|November 18, 2011
Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitorConstantin S Jianu, Ove J Lange, Trond Viset, et al.
Investigative Radiology|September 27, 2012
Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathologyKirsten M Selnæs, Arend Heerschap, Line R Jensen, et al.
Plos One|April 30, 2013
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressivenessGuro F Giskeødegård, Helena Bertilsson, Kirsten M Selnæs, et al.
Oncotarget|September 11, 2018
"Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signalingCaroline Krogh Søgaard, Augun Blindheim, Lisa M Røst, et al.
Oncotarget|June 9, 2016
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancerAilin Falkmo Hansen, Elise Sandsmark, Morten Beck Rye, et al.
Oncotarget|December 29, 2016
A novel non-canonical Wnt signature for prostate cancer aggressivenessElise Sandsmark, Ailin Falkmo Hansen, Kirsten M Selnæs, et al.
Communications Biology|November 7, 2024
Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancerMaria K Andersen, Sebastian Krossa, Elise Midtbust, et al.
Nature Communications|November 19, 2025
Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironmentSebastian Krossa, Maria K Andersen, Elise M Sandholm, et al.
Pageof 4